Greenwich LifeSciences Files 2024 10-K
Ticker: GLSI · Form: 10-K · Filed: Apr 15, 2025 · CIK: 1799788
| Field | Detail |
|---|---|
| Company | Greenwich Lifesciences, Inc. (GLSI) |
| Form Type | 10-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, financials, pharmaceuticals
TL;DR
GLSI filed its 2024 10-K. Financials for 2022-2024 are in. Check it out.
AI Summary
Greenwich LifeSciences, Inc. filed its 2024 10-K on April 15, 2025, reporting on its fiscal year ending December 31, 2024. The company, based in Stafford, Texas, operates in the pharmaceutical preparations sector. Key financial data for common stock, additional paid-in capital, and retained earnings are reported for the fiscal years 2022, 2023, and 2024.
Why It Matters
This filing provides investors with the company's audited financial performance and operational details for the 2024 fiscal year, crucial for understanding its financial health and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Greenwich LifeSciences faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.
Key Numbers
- 2024-12-31 — Fiscal Year End (The end date of the reporting period for the 10-K.)
- 2025-04-15 — Filing Date (The date the 10-K was officially submitted to the SEC.)
- 2022-12-31 — Prior Fiscal Year End (Provides comparative financial data for previous periods.)
- 2023-12-31 — Prior Fiscal Year End (Provides comparative financial data for previous periods.)
Key Players & Entities
- Greenwich LifeSciences, Inc. (company) — Filer of the 10-K report
- 2024-12-31 (date) — Fiscal year end for the reported period
- 2025-04-15 (date) — Filing date of the 10-K
- Stafford, TX (location) — Business and mailing address of the company
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary business of Greenwich LifeSciences, Inc.?
Greenwich LifeSciences, Inc. operates in the Pharmaceutical Preparations industry, as indicated by its SIC code 2834.
When was the 2024 10-K filing submitted to the SEC?
The 10-K filing for the fiscal year ending December 31, 2024, was submitted on April 15, 2025.
Where is Greenwich LifeSciences, Inc. located?
The company's business and mailing address is 3992 Bluebonnet Dr, Building 14, Stafford, TX 77477.
What financial periods are covered by the data in this 10-K filing?
The filing includes financial data for the fiscal years ending December 31, 2022, 2023, and 2024.
What is the SEC file number for Greenwich LifeSciences, Inc.?
The SEC file number for Greenwich LifeSciences, Inc. is 001-39555.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 15, 2025 regarding Greenwich LifeSciences, Inc. (GLSI).